Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands		Total	Cumulative effect upon adoption of new accounting standard	Total Equity (Deficit) Attributable to Common Stockholders	Total Equity (Deficit) Attributable to Common Stockholders Cumulative effect upon adoption of new accounting standard	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative effect upon adoption of new accounting standard	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit Cumulative effect upon adoption of new accounting standard	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2020						168,002,726
Beginning balance at Dec. 31, 2020		$ 141,019	$ (121,491)	$ 78,824	$ (121,491)	$ 17	$ 3,182,753	$ (126,799)	$ (9)	$ (3,103,937)	$ 5,308	$ 62,195
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock awards (in shares)						3,052,012
ESPP purchase (in shares)						1,945,305
ESPP purchase		10,045		10,045			10,045
Exercise of stock options (in shares)						3,460,364
Exercise of stock options		79,745		79,745		$ 1	79,744
Stock-based compensation		73,338		73,338			73,338
Distributions and payments to noncontrolling interest		(5,789)										(5,789)
Foreign currency translation adjustment		(595)
Change in effective portion of interest rate swap agreement		15,243										15,243
Foreign currency translation adjustment		(596)		(342)					(341)	(1)		(254)
Net loss	[1]	(193,341)		(164,445)						(164,445)		(28,896)
Ending balance (in shares) at Dec. 31, 2021						176,460,407
Ending balance at Dec. 31, 2021		(1,827)		(44,326)		$ 18	3,219,081		(350)	(3,263,075)		42,499
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock awards (in shares)						2,957,215
ESPP purchase (in shares)						759,744
ESPP purchase		11,600		11,600			11,600
Exercise of stock options (in shares)						537,324
Exercise of stock options		3,679		3,679			3,679
Stock-based compensation		112,722		112,722			112,722
Contributions from noncontrolling interest		2,815										2,815
Distributions and payments to noncontrolling interest		(6,854)		(500)			(500)					(6,354)
Buyout of noncontrolling interest		(12,000)		(24,350)			(24,350)					12,350
Conversion of Series B redeemable convertible preferred stock (in shares)						10,000,000
Conversion of redeemable convertible preferred stock		208,551		208,551		$ 1	208,550
Foreign currency translation adjustment		(794)		(901)					(901)			107
Public share offering (in shares)						14,950,000
Public share offering		371,527		371,527		$ 1	371,526
Forward contract to purchase Class A Common Stock		4,183		4,183			4,183
Net loss	[2]	(314,786)		(301,408)						(301,408)		(13,378)
Ending balance (in shares) at Dec. 31, 2022						205,664,690
Ending balance at Dec. 31, 2022		378,816		340,777		$ 20	3,906,491		(1,251)	(3,564,483)		38,039
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock awards (in shares)						4,160,416
ESPP purchase (in shares)						875,695
ESPP purchase		13,363		13,363			13,363
Exercise of stock options (in shares)						525,031
Exercise of stock options		3,582		3,582			3,582
Stock-based compensation		87,076		87,076			87,076
Contributions from noncontrolling interest		6,979										6,979
Distributions and payments to noncontrolling interest		(2,265)										(2,265)
Buyout of noncontrolling interest		(6,864)		11,482			11,482					(18,346)
Derecognition of the pre-modified forward contract fair value		76,242		76,242			76,242
Equity component of redeemable convertible preferred stock		16,145		16,145			16,145
Purchase of capped call options related to convertible notes		(54,522)		(54,522)			(54,522)
Conversion of Series B redeemable convertible preferred stock (in shares)						13,491,701
Conversion of redeemable convertible preferred stock		310,485		310,485		$ 1	310,484
Foreign currency translation adjustment		(430)		(436)					(436)			6
Net loss		(307,937)		(302,116)						(302,116)		(5,821)
Ending balance (in shares) at Dec. 31, 2023						224,717,533
Ending balance at Dec. 31, 2023		$ 520,670		$ 502,078		$ 21	$ 4,370,343		$ (1,687)	$ (3,866,599)		$ 18,592

[1] 2 Excludes $28 attributable to redeemable noncontrolling interest. Note: Beginning redeemable NCI of $377 — distributions to redeemable noncontrolling interests of $49 — Net loss attributable to redeemable NCI of $28 = Ending redeemable NCI of $300.

[2] 1 Excludes $300 attributable to redeemable noncontrolling interest. Note: Beginning redeemable NCI of $300 — Net loss attributable to redeemable NCI of $300 = Ending redeemable NCI of Nil.